Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Australia Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20082
20092
20111
20121
20132
20142
201510
20161
20179
20183
20197
20206
202112
20225
20233
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Pfizer8
Hoffmann-La Roche6
BeiGene3
Bristol-Myers Squibb3
Clovis Oncology, Inc.3
MacroGenics3
Amgen2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung75
Neoplasm Metastasis14
Colorectal Neoplasms12
Melanoma12
Neoplasms11
Squamous Cell Carcinoma of Head and Neck9
Lung Neoplasms8
Head and Neck Neoplasms5
Pancreatic Neoplasms5
Triple Negative Breast Neoplasms5

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.